Literature DB >> 25512456

American Society of Clinical Oncology policy statement update: the critical role of phase I trials in cancer research and treatment.

Jeffrey S Weber1, Laura A Levit2, Peter C Adamson2, Suanna Bruinooge2, Howard A Burris2, Michael A Carducci2, Adam P Dicker2, Mithat Gönen2, Stephen M Keefe2, Michael A Postow2, Michael A Thompson2, David M Waterhouse2, Susan L Weiner2, Lynn M Schuchter2.   

Abstract

Entities:  

Mesh:

Year:  2014        PMID: 25512456      PMCID: PMC4516884          DOI: 10.1200/JCO.2014.58.2635

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  85 in total

1.  Effect of the accountable care act of 2010 on clinical trial insurance coverage.

Authors:  Sheetal M Kircher; Al B Benson; Matthew Farber; Halla S Nimeiri
Journal:  J Clin Oncol       Date:  2011-12-27       Impact factor: 44.544

2.  Medical assessment of adverse health outcomes in long-term survivors of childhood cancer.

Authors:  Maud M Geenen; Mathilde C Cardous-Ubbink; Leontien C M Kremer; Cor van den Bos; Helena J H van der Pal; Richard C Heinen; Monique W M Jaspers; Caro C E Koning; Foppe Oldenburger; Nelia E Langeveld; Augustinus A M Hart; Piet J M Bakker; Huib N Caron; Flora E van Leeuwen
Journal:  JAMA       Date:  2007-06-27       Impact factor: 56.272

Review 3.  Clinical trials of antitumor agents: experimental design and timeline considerations.

Authors:  E Frei
Journal:  Cancer J Sci Am       Date:  1997 May-Jun

4.  The culture of faith and hope: patients' justifications for their high estimations of expected therapeutic benefit when enrolling in early phase oncology trials.

Authors:  Daniel P Sulmasy; Alan B Astrow; M Kai He; Damon M Seils; Neal J Meropol; Ellyn Micco; Kevin P Weinfurt
Journal:  Cancer       Date:  2010-08-01       Impact factor: 6.860

5.  Trends in the risks and benefits to patients with cancer participating in phase 1 clinical trials.

Authors:  Thomas G Roberts; Bernardo H Goulart; Lee Squitieri; Sarah C Stallings; Elkan F Halpern; Bruce A Chabner; G Scott Gazelle; Stan N Finkelstein; Jeffrey W Clark
Journal:  JAMA       Date:  2004-11-03       Impact factor: 56.272

6.  Topotecan, an active drug in the second-line treatment of epithelial ovarian cancer: results of a large European phase II study.

Authors:  G J Creemers; G Bolis; M Gore; G Scarfone; A J Lacave; J P Guastalla; R Despax; G Favalli; R Kreinberg; S Van Belle; I Hudson; J Verweij; W W Ten Bokkel Huinink
Journal:  J Clin Oncol       Date:  1996-12       Impact factor: 44.544

7.  Risks and benefits of phase 1 oncology trials, 1991 through 2002.

Authors:  Elizabeth Horstmann; Mary S McCabe; Louise Grochow; Seiichiro Yamamoto; Larry Rubinstein; Troy Budd; Dale Shoemaker; Ezekiel J Emanuel; Christine Grady
Journal:  N Engl J Med       Date:  2005-03-03       Impact factor: 91.245

8.  Therapeutic response in phase I trials of antineoplastic agents.

Authors:  E Estey; D Hoth; R Simon; S Marsoni; B Leyland-Jones; R Wittes
Journal:  Cancer Treat Rep       Date:  1986-09

9.  Health status of long-term survivors after cancer in childhood. Results of an uniinstitutional study in Italy.

Authors:  M L Garrè; S Gandus; B Cesana; R Haupt; B De Bernardi; A Comelli; A Ferrando; G Stella; M L Vitali; P Picco
Journal:  Am J Pediatr Hematol Oncol       Date:  1994-05

10.  Activity and safety of crizotinib in patients with ALK-positive non-small-cell lung cancer: updated results from a phase 1 study.

Authors:  D Ross Camidge; Yung-Jue Bang; Eunice L Kwak; A John Iafrate; Marileila Varella-Garcia; Stephen B Fox; Gregory J Riely; Benjamin Solomon; Sai-Hong I Ou; Dong-Wan Kim; Ravi Salgia; Panagiotis Fidias; Jeffrey A Engelman; Leena Gandhi; Pasi A Jänne; Daniel B Costa; Geoffrey I Shapiro; Patricia Lorusso; Katherine Ruffner; Patricia Stephenson; Yiyun Tang; Keith Wilner; Jeffrey W Clark; Alice T Shaw
Journal:  Lancet Oncol       Date:  2012-09-04       Impact factor: 41.316

View more
  36 in total

1.  Conceptual Model for Accrual to Cancer Clinical Trials.

Authors:  Simon J Craddock Lee; Caitlin C Murphy; Ann M Geiger; David E Gerber; John V Cox; Rasmi Nair; Celette Sugg Skinner
Journal:  J Clin Oncol       Date:  2019-06-05       Impact factor: 44.544

Review 2.  Precision medicine needs randomized clinical trials.

Authors:  Everardo D Saad; Xavier Paoletti; Tomasz Burzykowski; Marc Buyse
Journal:  Nat Rev Clin Oncol       Date:  2017-02-07       Impact factor: 66.675

3.  Discordant attitudes and beliefs about cancer clinical trial participation between physicians, research staff, and cancer patients.

Authors:  Grace C Hillyer; Melissa Beauchemin; Dawn L Hershman; Moshe Kelsen; Frances L Brogan; Rossy Sandoval; Karen M Schmitt; Andria Reyes; Mary Beth Terry; Andrew B Lassman; Gary K Schwartz
Journal:  Clin Trials       Date:  2020-02-03       Impact factor: 2.486

4.  The State of Cancer Care in America, 2016: A Report by the American Society of Clinical Oncology.

Authors: 
Journal:  J Oncol Pract       Date:  2016-03-15       Impact factor: 3.840

Review 5.  Challenges Facing Early Phase Trials Sponsored by the National Cancer Institute: An Analysis of Corrective Action Plans to Improve Accrual.

Authors:  Holly A Massett; Grace Mishkin; Larry Rubinstein; S Percy Ivy; Andrea Denicoff; Elizabeth Godwin; Kate DiPiazza; Jennifer Bolognese; James A Zwiebel; Jeffrey S Abrams
Journal:  Clin Cancer Res       Date:  2016-07-11       Impact factor: 12.531

Review 6.  Is Participation in Cancer Phase I Trials Really Therapeutic?

Authors:  Jonathan Kimmelman
Journal:  J Clin Oncol       Date:  2016-09-30       Impact factor: 44.544

7.  Insurance Clearance for Early-Phase Oncology Clinical Trials Following the Affordable Care Act.

Authors:  Kenneth L Kehl; Cheryl P Fullmer; Siqing Fu; Goldy C George; Kenneth R Hess; Filip Janku; Daniel D Karp; Shumei Kato; Cynthia K Kizer; Razelle Kurzrock; Aung Naing; Shubham Pant; Sarina A Piha-Paul; Vivek Subbiah; Apostolia M Tsimberidou; David S Hong
Journal:  Clin Cancer Res       Date:  2017-07-20       Impact factor: 12.531

8.  Patient and family member perspectives on searching for cancer clinical trials: A qualitative interview study.

Authors:  Jennifer L Ridgeway; Gladys B Asiedu; Katherine Carroll; Meaghan Tenney; Aminah Jatoi; Carmen Radecki Breitkopf
Journal:  Patient Educ Couns       Date:  2016-08-22

9.  Cancer Signature Investigation: ERBB2 (HER2)-Activating Mutation and Amplification-Positive Breast Carcinoma Mimicking Lung Primary.

Authors:  Jennifer Shih; Babar Bashir; Karen S Gustafson; Mark Andrake; Roland L Dunbrack; Lori J Goldstein; Yanis Boumber
Journal:  J Natl Compr Canc Netw       Date:  2015-08       Impact factor: 11.908

10.  Increasing complexity in oncology phase I clinical trials.

Authors:  Laeeq Malik; David Lu
Journal:  Invest New Drugs       Date:  2018-11-16       Impact factor: 3.850

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.